Totals
- Total revenue
- $686,191,950
- Total expenses
- $723,148,230
- Contributions and grants received
- $16,961,581
- Grants paid
- $1,686,667
- Program service revenue
- $648,909,055
- Investment income
- -$6,795,247
- Other revenue
- $27,116,561
- Total assets, end of year
- $830,626,770
- Total liabilities, end of year
- $227,931,983
- Net assets or fund balances, end of year
- $602,694,787
- Program services expenses (Part IX)
- $602,362,583
- Management and general expenses
- $120,785,647
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $602,362,583
Program services were 83.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1d · Related organizations
$14,264,810
-
1f · All other contributions, gifts and grants
$2,696,771
-
1g · Noncash contributions included above
$300,935
-
2a · Program service revenue: BLOOD & COMPONENT SRV FEE
total $510,363,136 · related or exempt $510,363,136
-
2b · Program service revenue: LABORATORY SERVICES
total $80,616,189 · related or exempt $80,616,189
-
2c · Program service revenue: PLASMA FOR FRACTIONATION
total $37,016,662 · related or exempt $37,016,662
-
2d · Program service revenue: RESEARCH CONTRACTS
total $20,868,792 · related or exempt $20,868,792
-
2e · Program service revenue: PHARMACEUTICAL PRODUCTS
total $44,276 · related or exempt $44,276
-
2f · All other program service revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
3 · Investment income
total $10,338,099 · excluded $10,338,099
-
5 · Royalties
total $38,228 · excluded $38,228
-
6a · Gross rents
real property $1,989,775
-
6c · Rental income or loss
real property $1,989,775 · personal property $0
-
6d · Net rental income or loss
total $1,989,775 · excluded $1,989,775
-
7a · Gross sales of assets other than inventory
securities $244,548,963 · other assets $1,300
-
7b · Less cost or other basis and sales expenses
securities $261,333,900 · other assets $349,709
-
7c · Gain or loss
securities -$16,784,937 · other assets -$348,409
-
7d · Net gain or loss
total -$17,133,346 · excluded -$17,133,346
-
11a · Other revenue: MISCELLANEOUS INCOME
total $24,034,168 · related or exempt $24,034,168
-
11b · Other revenue: NON-OPERATING MISC INCOME
total $1,054,390 · related or exempt $1,054,390
-
11d · All other revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
11e · Other revenue, total
$25,088,558
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,686,667 · program services $1,686,667
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $6,760,857 · management and general $6,760,857
-
7 · Other salaries and wages
total $313,932,883 · program services $262,382,978 · management and general $51,549,905
-
8 · Pension plan contributions
total $15,751,882 · program services $11,564,081 · management and general $4,187,801
-
9 · Other employee benefits
total $45,568,704 · program services $40,453,405 · management and general $5,115,299
-
10 · Payroll taxes
total $23,811,924 · program services $19,848,674 · management and general $3,963,250
-
11b · Fees: legal
total $1,168,208 · management and general $1,168,208
-
11c · Fees: accounting
total $98,114 · management and general $98,114
-
11d · Fees: lobbying
total $12,500 · management and general $12,500
-
11f · Fees: investment management
total $654,775 · management and general $654,775
-
11g · Fees: other
total $8,918,391 · program services $3,692,409 · management and general $5,225,982 · fundraising $0
-
12 · Advertising and promotion
total $7,174,374 · program services $936,300 · management and general $6,238,074
-
13 · Office expenses
total $48,115,275 · program services $39,498,747 · management and general $8,616,528
-
14 · Information technology
total $19,691,395 · program services $9,029,707 · management and general $10,661,688
-
16 · Occupancy
total $41,854,989 · program services $38,409,208 · management and general $3,445,781
-
17 · Travel
total $15,883,967 · program services $14,812,675 · management and general $1,071,292
-
20 · Interest
total $1,220,992 · management and general $1,220,992
-
22 · Depreciation, depletion and amortization
total $19,615,279 · program services $14,753,488 · management and general $4,861,791
-
23 · Insurance
total $5,050,188 · program services $4,627,915 · management and general $422,273
-
24a · Other expenses: OPERATING & TESTING SUPPLIES
total $131,611,513 · program services $130,661,616 · management and general $949,897
-
24b · Other expenses: RESEARCH COSTS
total $4,258,328 · program services $4,258,328
-
24c · Other expenses: DONOR RECOGNITION & PROMO
total $3,637,817 · program services $1,414,867 · management and general $2,222,950
-
24d · Other expenses: PHARM/BLOOD PROD PURCHASE
total $2,321,320 · program services $2,321,320
-
24e · All other expenses
total $4,347,888 · program services $2,010,198 · management and general $2,337,690 · fundraising $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $71,724,969 · end of year $22,906,880
-
2 · Savings and temporary cash investments
beginning of year $110,576 · end of year $0
-
4 · Accounts receivable
beginning of year $105,395,447 · end of year $112,303,786
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $225,251 · end of year $4,530,047
-
8 · Inventories for sale or use
beginning of year $19,324,190 · end of year $23,074,501
-
9 · Prepaid expenses and deferred charges
beginning of year $10,550,791 · end of year $12,189,476
-
10a · Land, buildings and equipment: cost or other basis
$458,796,732
-
10b · Land, buildings and equipment: accumulated depreciation
$253,544,364
-
10c · Land, buildings and equipment, net
beginning of year $191,272,378 · end of year $205,252,368
-
11 · Investments: publicly traded securities
beginning of year $281,792,701 · end of year $283,050,436
-
12 · Investments: other securities
beginning of year $2,808,716 · end of year $16,844,051
-
13 · Investments: program-related
beginning of year $46,104,561 · end of year $74,820,565
-
14 · Intangible assets
beginning of year $76,164,325 · end of year $70,068,299
-
15 · Other assets
beginning of year $5,161,205 · end of year $5,586,361
-
17 · Accounts payable and accrued expenses
beginning of year $81,171,924 · end of year $83,774,711
-
18 · Grants payable
beginning of year $1,026,072 · end of year $756,699
-
19 · Deferred revenue
beginning of year $2,758,473 · end of year $1,902,536
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $22,579,858 · end of year $36,337,681
-
25 · Other liabilities
beginning of year $127,969,348 · end of year $105,160,356
-
27 · Net assets without donor restrictions
beginning of year $574,975,087 · end of year $602,667,337
-
28 · Net assets with donor restrictions
beginning of year $154,348 · end of year $27,450
Mission and programs · 2023
Mission
UNITE BLOOD AND BIOLOGICS DONORS, TALENT, AND INNOVATION TO SAVE AND IMPROVE LIVES.
-
BLOOD SERVICES DIVISION - BLOOD BANKING THE PRIMARY PURPOSE OF THE BLOOD SERVICES DIVISION (BSD) IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF BSD IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. BSD COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELL PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS.
Expenses $522,502,772 · Grants $1,686,667 · Revenue $579,070,693
-
VITALANT LABORATORIES (VL) - VITALANT LABORATORIES' STAFF OF HIGHLY TRAINED AND EXPERIENCED PERSONNEL PROVIDE SUPPORT AND EXPERTISE TO HOSPITALS, TRANSFUSION AND TRANSPLANT CENTERS AND OTHER HEALTHCARE FACILITIES FOR THEIR TRANSFUSION MEDICINE NEEDS. VL OPERATES EIGHTEEN LABORATORIES FOR (IRL) IMMUNOHEMATOLOGY REFERENCE LAB, THREE (HLA) HISTOCOMPATIBILITY LABORATORIES AND FOUR (CTL) CELLULAR THERAPY LABORATORIES. TOGETHER THEY SOLVE SOME OF THE MOST COMPLEX IMMUNOHEMATOLOGIC COMPATIBILITY CASES AND ENSURE LIFE-SAVING BLOOD AND CELLULAR THERAPY SERVICES TO HOSPITALS ALL ACROSS THE UNITED STATES. FOR HEALTHCARE FACILITIES IN MULTIPLE STATES, VL ALSO SERVES AS A BLOOD BANK, PROVIDING COMPLETE TRANSFUSION SERVICES INCLUDING PATIENT COMPATIBILITY TESTING AND DELIVERY.
Expenses $44,992,995 · Revenue $63,872,048
-
VITALANT RESEARCH INSTITUTE (VRI) - THE VITALANT RESEARCH INSTITUTE CARRIES OUT STUDIES FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHER AGENCIES) AND RECEIVES INTRAMURAL FUNDING FROM VITALANT BETWEEN $5.0M AND $7.0M EACH YEAR. VRI HAS HISTORICALLY BEEN NOTED FOR CONTRIBUTIONS TO INFECTIOUS DISEASE TESTING / MONITORING, EPIDEMIOLOGY / PUBLIC POLICY, AND SELECTED NON-INFECTIOUS RISKS OF TRANSFUSION. RECENT RESEARCH EFFORTS INCLUDE CHARACTERIZATION OF METABOLIC AND GENETIC FACTORS THAT INFLUENCE RED BLOOD CELL STABILITY, AND SINCE THE PANDEMIC, A HOST OF CRITICALLY IMPORTANT STUDIES TO UNDERSTAND SARS-COV-2 EPIDEMIOLOGY, THE SAFETY OF THE BLOOD SUPPLY, THE TIME COURSE OF ITS ANTIBODY RESPONSE/IMMUNITY AND THE EFFICACY OF COVID CONVALESCENT PLASMA. A PUBLIC SERVICE, VRI'S RESEARCH EXTENDS FAR BEYOND ORGANIZATIONAL DEVELOPMENT EFFORTS, BENEFITING PATIENTS ALL OVER THE US (AND THE WORLD) AS WELL AS COMPETING US BLOOD CENTERS, IMPROVING BLOOD PRODUCT QUALITY, RECIPIENT SAFETY, AND THE DONOR EXPERIENCE. VRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF RESEARCH SCIENTISTS IN A HOST OF TRANSFUSION MEDICINE SUBSPECIALTIES. VRI INVESTIGATORS PUBLISHED MORE THAN 100 PEER-REVIEWED ORIGINAL RESEARCH PAPERS IN 2023 ALONG WITH MANY MORE REVIEWS, EDITORIALS, BOOK CHAPTERS AND SCIENTIFIC MEETING ABSTRACTS. TOGETHER, VRI'S 12 INVESTIGATORS, 2 CLINICAL INVESTIGATORS, 16 AFFILIATED INVESTIGATORS, 6 CORE LEADERS, 10 ADMINISTRATIVE STAFF AND ~70 SCIENTISTS, TECHNOLOGISTS AND POST-DOCS HAVE CONTRIBUTED TO MAJOR DISCOVERIES IN TRANSFUSION SAFETY AND EFFICACY.
Expenses $34,866,816 · Revenue $31,054,872
As filed on the 2023 return.
Listed in Part VII
-
Bill GatesBILL GATES
TRUSTEE/VICE CHAIR
- Total calculated
- $40,000
- From this org
- $40,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 3
-
James T SchraithJAMES T SCHRAITH
TRUSTEE/CHAIR
- Total calculated
- $71,750
- From this org
- $71,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 4 + 1 related
-
Paul E Stander MDPAUL E STANDER MD
TRUSTEE/SECRETARY & TREASURER (THRU 04/23)
- Total calculated
- $34,625
- From this org
- $34,625
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Cindy ElkinsCINDY ELKINS
TRUSTEE
- Total calculated
- $37,500
- From this org
- $37,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Clifford Lowell MD PhDCLIFFORD LOWELL MD PHD
TRUSTEE
- Total calculated
- $35,000
- From this org
- $35,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Heather J Allen MDHEATHER J ALLEN MD
TRUSTEE
- Total calculated
- $43,750
- From this org
- $43,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2 + 1 related
-
Jeffery ShumwayJEFFERY SHUMWAY
TRUSTEE
- Total calculated
- $33,750
- From this org
- $33,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
John S LewisJOHN S LEWIS
TRUSTEE
- Total calculated
- $48,625
- From this org
- $48,625
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2 + 2 related
-
Jonathan Waters MDJONATHAN WATERS MD
TRUSTEE
- Total calculated
- $33,750
- From this org
- $33,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Kathleen S PushorKATHLEEN S PUSHOR
TRUSTEE
- Total calculated
- $33,750
- From this org
- $33,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Patricia Abrego-SantucciPATRICIA ABREGO-SANTUCCI
TRUSTEE
- Total calculated
- $52,875
- From this org
- $52,875
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Robert S ColeROBERT S COLE
TRUSTEE
- Total calculated
- $54,750
- From this org
- $54,750
- From related orgs
- $0
- Other
- $0
- Hours/week
- 4
-
Ron W Waeckerlin MDRON W WAECKERLIN MD
TRUSTEE
- Total calculated
- $45,500
- From this org
- $45,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Sunny P ChicoSUNNY P CHICO
TRUSTEE
- Total calculated
- $46,250
- From this org
- $46,250
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2 + 1 related
-
William A Dittman MDWILLIAM A DITTMAN MD
TRUSTEE (THRU 11/23)
- Total calculated
- $36,000
- From this org
- $36,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 2
-
Bhavi ShahBHAVI SHAH
EVP/CHIEF LEGAL OFFICER/GENERAL COUNSEL
- Total calculated
- $664,127
- From this org
- $593,404
- From related orgs
- $0
- Other
- $70,723
- Hours/week
- 40 + 15 related
Schedule J breakdown matched by us
- Base
- $508,595
- Bonus
- $73,365
- Other
- $11,444
- Deferred
- $22,500
- Nontaxable benefits
- $48,223
- Filer's total
- $664,127
-
David GreenDAVID GREEN
PRESIDENT/CEO
- Total calculated
- $1,250,123
- From this org
- $1,199,347
- From related orgs
- $0
- Other
- $50,776
- Hours/week
- 55 + 1 related
Schedule J breakdown matched by us
- Base
- $989,205
- Bonus
- $194,597
- Other
- $15,545
- Deferred
- $30,000
- Nontaxable benefits
- $20,776
- Filer's total
- $1,250,123
-
Maureen MusselmanMAUREEN MUSSELMAN
EVP/Chief Financial Officer
- Total calculated
- $592,746
- From this org
- $545,429
- From related orgs
- $0
- Other
- $47,317
- Hours/week
- 40 + 15 related
Schedule J breakdown matched by us
- Base
- $464,604
- Bonus
- $66,236
- Other
- $14,589
- Deferred
- $26,629
- Nontaxable benefits
- $20,688
- Filer's total
- $592,746
-
Robert Van TuyleROBERT VAN TUYLE
EVP/CHIEF OPERATIONS OFFICER
- Total calculated
- $763,184
- From this org
- $698,296
- From related orgs
- $0
- Other
- $64,888
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $598,859
- Bonus
- $86,415
- Other
- $13,022
- Deferred
- $30,000
- Nontaxable benefits
- $34,888
- Filer's total
- $763,184
-
Anthony BobosANTHONY BOBOS
EVP/CHIEF INFORMATION OFFICER
- Total calculated
- $569,568
- From this org
- $509,849
- From related orgs
- $0
- Other
- $59,719
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $419,341
- Bonus
- $65,777
- Other
- $24,731
- Deferred
- $25,374
- Nontaxable benefits
- $34,345
- Filer's total
- $569,568
-
Dirk JohnsonDIRK JOHNSON
EVP/CHIEF OF STAFF
- Total calculated
- $495,996
- From this org
- $438,479
- From related orgs
- $0
- Other
- $57,517
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $358,856
- Bonus
- $55,372
- Other
- $24,251
- Deferred
- $22,010
- Nontaxable benefits
- $35,507
- Filer's total
- $495,996
-
Mary Beth BassettMARY BETH BASSETT
EVP/CHIEF QUALITY OFFICER
- Total calculated
- $594,804
- From this org
- $547,191
- From related orgs
- $0
- Other
- $47,613
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $463,231
- Bonus
- $64,490
- Other
- $19,470
- Deferred
- $26,589
- Nontaxable benefits
- $21,024
- Filer's total
- $594,804
-
Peter MichaelsonPETER MICHAELSON
EVP/CHIEF PEOPLE OFFICER
- Total calculated
- $543,723
- From this org
- $477,968
- From related orgs
- $0
- Other
- $65,755
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $393,680
- Bonus
- $57,579
- Other
- $26,709
- Deferred
- $23,597
- Nontaxable benefits
- $42,158
- Filer's total
- $543,723
-
Ralph VassalloRALPH VASSALLO
EVP/CHIEF MEDICAL & SCIENTIFIC OFFICER
- Total calculated
- $638,711
- From this org
- $587,936
- From related orgs
- $0
- Other
- $50,775
- Hours/week
- 54 + 1 related
Schedule J breakdown matched by us
- Base
- $498,126
- Bonus
- $75,833
- Other
- $13,977
- Deferred
- $29,508
- Nontaxable benefits
- $21,267
- Filer's total
- $638,711
-
Brian CusterBRIAN CUSTER
SVP, RESEARCH & SCIENTIFIC PROGRAMS
- Total calculated
- $570,143
- From this org
- $526,293
- From related orgs
- $0
- Other
- $43,850
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $475,737
- Bonus
- $48,652
- Other
- $1,904
- Deferred
- $16,500
- Nontaxable benefits
- $27,350
- Filer's total
- $570,143
-
Clifford NumarkCLIFFORD NUMARK
SVP, CHIEF STRAT MKT DONOR SVC
- Total calculated
- $483,271
- From this org
- $457,235
- From related orgs
- $0
- Other
- $26,036
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $408,282
- Bonus
- $48,703
- Other
- $250
- Deferred
- $16,500
- Nontaxable benefits
- $9,536
- Filer's total
- $483,271
-
Kevin LandKEVIN LAND
VP, CLINICAL SERVICES
- Total calculated
- $547,368
- From this org
- $482,435
- From related orgs
- $0
- Other
- $64,933
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $431,666
- Bonus
- $48,989
- Other
- $1,780
- Deferred
- $24,551
- Nontaxable benefits
- $40,382
- Filer's total
- $547,368
-
Mary TownsendMARY TOWNSEND
VP, CORPORATE MEDICAL DIRECTOR
- Total calculated
- $514,867
- From this org
- $453,454
- From related orgs
- $0
- Other
- $61,413
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $405,493
- Bonus
- $37,287
- Other
- $10,674
- Deferred
- $22,542
- Nontaxable benefits
- $38,871
- Filer's total
- $514,867
-
Michael Busch MDMICHAEL BUSCH MD
SVP, RESEARCH & SCIENTIFIC PROGRAMS
- Total calculated
- $561,408
- From this org
- $510,100
- From related orgs
- $0
- Other
- $51,308
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $438,091
- Bonus
- $45,264
- Other
- $26,745
- Deferred
- $24,955
- Nontaxable benefits
- $26,353
- Filer's total
- $561,408
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
- CERTAIN EMPLOYEES PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. THE FOLLOWING INDIVIDUALS EXPERIENCED A TAXABLE VESTING EVENT DURING THE YEAR AS FOLLOWS. THESE AMOUNTS WERE INCLUDED IN COLUMN (B)(III) AS TAXABLE WAGES. ANY PORTION OF THE DISTRIBUTION THAT WAS PREVIOUSLY REPORTED ON A PRIOR 990 AS DEFERRED HAS BEEN REPORTED IN COLUMN (F). ANTHONY BOBOS - $12,152 MICHAEL BUSCH, MD - $11,917 PETER MICHAELSON - $12,091 DIRK JOHNSON - $10,853 MAUREEN MUSSELMAN - $1,944 MARY TOWNSEND - $5,600
- Schedule J, Part I, Line 7 Non-fixed payments
- VITALANT HAS AN INCENTIVE PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN, FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
UNIV OF PITTSBURGH-DEPT OF MEDICINE
$1,500,000
ESTABLISH HEMOSTASIS CLINIC
-
$75,000
NFB/CORD SUPPORT
-
UNM FOUNDATION
$41,790
FELLOWSHIP SUPPORT
-
$25,000
DONATION
-
DONATION
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $25,629,405
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| Central America and the Caribbean | 0 | 0 | Program Services | CAPTIVE INSURANCE | $9,285,354 |
| Central America and the Caribbean | 0 | 0 | Investments | — | $16,344,051 |
- Transferred property to a foreign corporation during the year (line 1)
- Yes
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- Yes
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- Yes
- Had operations in or related to a boycotting country (line 6)
- No
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(c)(3) · FUNDRAISING · PA · controlled entity
Directly controlled by Vitalant
-
HEMOPHILIA CENTER OF WESTERN PA
501(c)(3) · HEMOPHILIA TREATMENT CENTER · PA · controlled entity
Directly controlled by VITALANT
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
CANYON STATE PROPERTY HOLDING LLC
HOLDING COMPANY · AZ · income $0 · assets $30,837,972
Directly controlled by VITALANT
-
PLASMASOURCE LLC
PLASMA COLLECTION · AZ · income $0 · assets $6,655,274
Directly controlled by VITALANT
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
CANYON STATE INSURANCE COMPANY
C Corporation · CAPTIVE INSURANCE · CJ · 100% owned · share of income -$1,543,006 · share of assets $37,080,467 · controlled entity
Directly controlled by VITALANT
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 30 October 2024
- IRS schema version
- 2023v5.1
- Source object
- 202403039349303025
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.